​

Funding Round

Series B - Attralus

Series B - Attralus

Investment Firm

Overview

Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.

Announced Date

Sep 08, 2021

Funding Type

Series B

Highlights

Location

United States, North America

Social

Investor Lead

Logos Capital

Logos Capital

Logos Capital is a early_stage_venture and post_ipo firm.

Participant Investors

5

Investor Name
Participant InvestorLogos Capital
Participant InvestorSarissa Capital Management
Participant InvestorRedmile Group
Participant InvestorvenBio Partners
Participant InvestorVivo Capital

Round Details and Background

Attralus raised $116000000 on 2021-09-08 in Series B

Attralus is a biopharmaceutical company focusing on creating transformative medicines to improve the lives of patients.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Sep 14, 2020
Series A - Attralus
1-25.0M
Sep 08, 2021
Series B - Attralus
8-116.0M
Feb 06, 2024
Series B - Attralus
7-56.0M

Recent Activity

There is no recent news or activity for this profile.